![How to Explain the Current State of EKRA to Your Lab Executives](https://www.g2intelligence.com/wp-content/uploads/2023/02/March23.LCA_.EKRA_.BriefCEO-iStock-1151640522_1800x1250-1080x675.jpg)
How to Explain the Current State of EKRA to Your Lab Executives
How to explain the current state of EKRA to your lab executives.
How to explain the current state of EKRA to your lab executives.
A template for creating a general code of conduct that sets out broad parameters and ground rules for compliance.
It’s imperative for labs to establish and maintain an active corporate compliance program that augments the actual scientific testing.
Sales and marketing operations liability risks and the measures labs should and shouldn’t take to manage those risks.
Key cases over the last month include a CGx testing kickback scheme, false billing, and violations of a non-compete clause and HIPAA.